EDIL3 and cardiovascular disorder: This would allow the investigation of crosstalk between DEL-1 and other regulators of angiogenesis, thereby advancing our understanding of the role of DEL-1 in cardiovascular disease treatment (Cabrera and Makino, 2022; Zhao et al., 2022).